A copy of the intellectual property chapter of the Trans-Pacific Partnership Agreement has been posted by Wikileaks. The chapter includes the details on the issues of trademarks, patents, pharmaceutical products, biologics, copyright, IP enforcement, border measures and ISPs. See my earlier post on the TPP.
Australia’s highest court has issued its decision in D’Arcy v Myriad Genetics Inc, allowing the appeal and holding that claims directed to the BRCA1 gene be revoked on the basis that the substance of the claim “is information embodied in arrangements of nucleotides” and not a “manner of manufacture.” Continue reading Australian Myriad
Twelve countries, including Canada, have agreed to the Trans-Pacific Partnership. No text has been released yet but reports are that protection of biologics was one of the final sticking points. The government has posted a high level summary on the IP issues in the agreement. Continue reading TPP
The Federal Court has issued a discussion paper on costs in the Federal Court. A subcommittee of the Federal Courts Rules committee is seeking comments by November 23, 2015 on costs, including on addressing improper, vexatious and unnecessary litigation, access to justice and methods of calculating costs.